Volume 10, Number 7—July 2004
Research
Rapid Assessment Tool for Haemophilus influenzae type b Disease in Developing Countries1
Daniel R. Feikin*
, Christopher B. Nelson†, James P. Watt*‡, Ezzeddine Mohsni§, Jay D. Wenger†, and Orin S. Levine*‡
, Christopher B. Nelson†, James P. Watt*‡, Ezzeddine Mohsni§, Jay D. Wenger†, and Orin S. Levine*‡
Table 2
Results of Haemophilus influenzae type b (Hib) rapid assessment tool in 11 developing countries
| Country | Under-5 mortality rate | Cases/deathsa | Cases/deathsb |
|---|---|---|---|
| Ghana |
110 |
5,465/984 |
27,326/4,099 |
| Uganda |
147 |
2,838/709 |
14,189/2,838 |
| Egypt |
65 |
6,731/2558 |
33,657/2,019 |
| Iran |
31.5 |
1,975/40 |
9,876/593 |
| Jordan |
33 |
313/16 |
1,563/78 |
| Morocco |
Not done |
||
| Oman |
21.5 |
48/15 |
242/14 |
| Yemen |
105 |
3,085/956 |
15,427/956 |
| Kyrgyzstan |
19.6 i |
125/15 |
625/63 |
| Uzbekistan |
21g |
565/68 |
2,826/283 |
| Bhutan | 63g | 54/18 | 270/27 |
aNational Hib meningitis.
bNational Hib pneumonia.
1Some of the content of this manuscript has previously been presented in a document on the Web site of the World Health Organization (http://www.who.int/vaccines-documents/DocsPDF01/www625.pdf).
Page created: January 27, 2011
Page updated: January 27, 2011
Page reviewed: January 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.